Skip to main content

Featured

Nigeria Balances Security Needs with Sovereignty in Response to U.S. Offer

Nigeria has stated that while it is open to receiving assistance from the United States in combating Islamist insurgents, such support must fully respect its sovereignty and territorial integrity. The announcement came after U.S. President Donald Trump warned of potential “fast” military action in Nigeria over what he described as the persecution of Christians in the country. Daniel Bwala, an adviser to Nigerian President Bola Tinubu, emphasized that Nigeria welcomes international cooperation in its fight against terrorism but will not compromise its independence. “We welcome U.S. assistance as long as it recognises our territorial integrity,” Bwala said, adding that dialogue between the two nations could lead to stronger joint efforts against extremist groups. Nigeria, Africa’s most populous nation with over 200 million people, has faced years of violence from Islamist insurgents, including Boko Haram and Islamic State West Africa Province (ISWAP). These groups have carried out dea...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment